Clinical Trial
. 1999 Feb;103(2):534-5; author reply 535-6.
Questions about palivizumab (Synagis)
- PMID: 10026068
Item in Clipboard
Clinical Trial
Questions about palivizumab (Synagis)
Pediatrics.
1999 Feb.
No abstract available
Comment on
-
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.Pediatrics. 1998 Sep;102(3 Pt 1):531-7. Pediatrics. 1998. PMID: 9738173 Clinical Trial.
-
Humanized monoclonal antibody for prevention of respiratory syncytial virus infection.Pediatrics. 1998 Sep;102(3 Pt 1):648-51. doi: 10.1542/peds.102.3.648. Pediatrics. 1998. PMID: 9738192 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical